Researchers have confirmed that the experimental vaccine developed by China to treat Covid-19 via the Institute of Medical Biology of the Chinese Academy of Medical Sciences has been proven safe at an early stage of clinical trials.
In a research paper published on Tuesday, the researchers said that the first phase trials conducted on 191 healthy participants between the ages of 18 and 59 years did not show severe negative reactions after receiving the trial injection vaccination, and the latest results were published on Medrxiv, a free server on The Internet is for complete manuscripts in medical and clinical sciences and related but unpublished health sciences, and what is published are tagged as “advance publications” meaning preliminary reports on trials and research that have not yet been approved by medical peer review.
According to the researchers, the most prominent negative reactions reported by the participants in the experiment were mild pain, fatigue, slight redness, itching and swelling at the injection site, and the study pointed out that the candidate vaccine caused an immune response.
According to the research paper, “All data obtained in this trial support the safety and immunity of this inactivated vaccine and are encouraging regarding further studies of its effectiveness in the future.”
China has vaccinated hundreds of thousands of essential workers and other high-risk groups with other vaccines, even as clinical trials are not fully completed, raising safety concerns among experts. Note that China has so far at least 4 experimental vaccines in the final stage of clinical trials.
These were the details of the news Study: Chinese experimental vaccine appears safe – Covid-19 for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at eg24.news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.